Parabolic Semiconductor Rally: What Breaks The Trade? Authored by Lance Roberts via RealInvestmentAdvice.com, AI Validation Fuels A Ninth Weekly Advance The headline tape made fresh history. The S&P 500 closed Friday at 7,580.06 , finishing up 1.43% on the week and posting its ninth consecutive weekly gain. That’s the longest weekly winning streak since 2024, and only the 5th time since 1965 that ...
Parabolic Semiconductor Rally: What Breaks The Trade? Authored by Lance Roberts via RealInvestmentAdvice.com, AI Validation Fuels A Ninth Weekly Advance The headline tape made fresh history. The S&P 500 closed Friday at 7,580.06 , finishing up 1.43% on the week and posting its ninth consecutive weekly gain. That’s the longest weekly winning streak since 2024, and only the 5th time since 1965 that has occurred. While markets previously saw weakness following such streaks, the 24- and 52-week outcomes were primarily positive, except in 1989. However, the Russell 2000 actually fell 0.59% to 2,919, a reminder that the small-cap participation everyone hoped for in March still hasn’t shown up despite the megacap rip. Underneath the headline, the dispersion that’s defined this rally has only widened. Technology and financials carried Friday’s tape while energy lagged on falling crude. Two macro stories collided midweek, and the market chose to celebrate one and shrug at the other. First, the April PCE inflation print landed Thursday morning with the highest headline reading in nearly three years at 3.8% year-over-year, with core PCE at 3.3%. However, the monthly core reading came in at 0.2%, below the 0.3% consensus, and that softer monthly tone gave the Fed-cut camp something to work with. Second, Axios reported Thursday that the US and Iran had reached a tentative 60-day Memorandum of Understanding to extend the ceasefire framework. Oil promptly slid to a six-week low near $89 WTI, the VIX collapsed to its lowest reading since January, ending the week at 15.32, and the rally accelerated. The combination of a softer core PCE and a reduced geopolitical premium handed equity bulls everything they wanted in two sessions. The dominant micro story came after the bell on Thursday. Dell Technologies reported fiscal Q1 results that were, by any measure, extraordinary, with revenue hitting a record $43.8 billion , up 88% year-over-year, $24.4 billion in AI orders booked, and $16.1...
Randolph Altschuler, Chief Executive Officer of Xometry (NASDAQ:XMTR) , reported the indirect sale of 50,000 shares for a transaction value of approximately $4.4 million on May 21, 2026, as disclosed in this SEC Form 4 filing . Transaction value based on SEC Form 4 weighted average purchase price ($87.85); post-transaction value based on May 21, 2026, market close ($87.85). * 1-year performance ca...
Randolph Altschuler, Chief Executive Officer of Xometry (NASDAQ:XMTR) , reported the indirect sale of 50,000 shares for a transaction value of approximately $4.4 million on May 21, 2026, as disclosed in this SEC Form 4 filing . Transaction value based on SEC Form 4 weighted average purchase price ($87.85); post-transaction value based on May 21, 2026, market close ($87.85). * 1-year performance calculated as of May 29, 2026. Continue reading
Peloton (NASDAQ:PTON) , a leader in connected fitness and digital subscriptions, reported a sale by its Chief Commercial Officer amid ongoing market challenges. Sanders Dion C., Chief Commercial Officer of Peloton, reported the sale of 112,523 directly held shares of common stock for a total transaction value of approximately $584,000, according to the SEC Form 4 filing . Transaction value based o...
Peloton (NASDAQ:PTON) , a leader in connected fitness and digital subscriptions, reported a sale by its Chief Commercial Officer amid ongoing market challenges. Sanders Dion C., Chief Commercial Officer of Peloton, reported the sale of 112,523 directly held shares of common stock for a total transaction value of approximately $584,000, according to the SEC Form 4 filing . Transaction value based on SEC Form 4 weighted average purchase price ($5.19); post-transaction value was $0.00, as all shares were sold. Continue reading
BorgWarner (NYSE: BWA) is a name investors associate with turbochargers and drivetrains, but now it's thrown its hat into the hyperscaler ring. In February, the company signed a master supply agreement to provide modular turbine generators to help power data centers. The deal with TurboCell, a subsidiary of infrastructure developer Endeavor, marks an important entry into the industrial power marke...
BorgWarner (NYSE: BWA) is a name investors associate with turbochargers and drivetrains, but now it's thrown its hat into the hyperscaler ring. In February, the company signed a master supply agreement to provide modular turbine generators to help power data centers. The deal with TurboCell, a subsidiary of infrastructure developer Endeavor, marks an important entry into the industrial power market. Management expects production to begin in 2027, with sales exceeding $300 million in the first year and the potential to grow in the "mid-teens" over the coming decade. Image source: Getty Images. Continue reading
Carl Dambkowski, Director of Oruka Therapeutics (NASDAQ:ORKA) , reported the sale of 105,000 shares of Common Stock for a total of approximately $6.19 million on May 21, 2026, according to a SEC Form 4 filing . Transaction value based on SEC Form 4 weighted average purchase price ($58.97); post-transaction value based on May 21, 2026, market close ($58.69). * 1-year performance calculated using Ma...
Carl Dambkowski, Director of Oruka Therapeutics (NASDAQ:ORKA) , reported the sale of 105,000 shares of Common Stock for a total of approximately $6.19 million on May 21, 2026, according to a SEC Form 4 filing . Transaction value based on SEC Form 4 weighted average purchase price ($58.97); post-transaction value based on May 21, 2026, market close ($58.69). * 1-year performance calculated using May 28, 2026, as the reference date. Continue reading
Penalty misses from pre-season were repeated in Budapest while summer signings could help Gunners exert more control in biggest games When it was finally over – on the night and for the club season, devastation the overriding emotion for everyone connected to Arsenal – Declan Rice wanted to go back to make the point. To last July and his club’s first pre-season game, against Milan in Singapore. Ar...
Penalty misses from pre-season were repeated in Budapest while summer signings could help Gunners exert more control in biggest games When it was finally over – on the night and for the club season, devastation the overriding emotion for everyone connected to Arsenal – Declan Rice wanted to go back to make the point. To last July and his club’s first pre-season game, against Milan in Singapore. Arsenal won 1-0 before the teams agreed to stage a penalty shootout. The idea was clear: to practise in front of a crowd because you just cannot replicate this particular aspect of the game on the training ground. Arsenal lost. Continue reading...
Delancey W. Davis, President of Franklin Electric ‘s (NASDAQ:FELE) groundwater distribution segment, disclosed the sale of 1,900 shares of common stock for a transaction value of ~$190,000 on May 26, 2026, according to a SEC Form 4 filing . Transaction value based on SEC Form 4 reported price ($100.00); post-transaction value based on May 26, 2026, market close ($101.16). * 1-year performance calc...
Delancey W. Davis, President of Franklin Electric ‘s (NASDAQ:FELE) groundwater distribution segment, disclosed the sale of 1,900 shares of common stock for a transaction value of ~$190,000 on May 26, 2026, according to a SEC Form 4 filing . Transaction value based on SEC Form 4 reported price ($100.00); post-transaction value based on May 26, 2026, market close ($101.16). * 1-year performance calculated using May 28, 2026, as the reference date. Continue reading
According to an SEC filing dated May 15, 2026, Velan Capital Investment Management LP sold 140,000 shares of Mineralys Therapeutics in the first quarter. The estimated value of the trade was $4.11 million, based on the quarterly average share price. The move left the fund with 11,000 shares, valued at $297,990 at quarter-end. The net position value declined by $5.18 million, reflecting both share ...
According to an SEC filing dated May 15, 2026, Velan Capital Investment Management LP sold 140,000 shares of Mineralys Therapeutics in the first quarter. The estimated value of the trade was $4.11 million, based on the quarterly average share price. The move left the fund with 11,000 shares, valued at $297,990 at quarter-end. The net position value declined by $5.18 million, reflecting both share sales and price moves. Mineralys Therapeutics is a clinical-stage biotechnology company based in Radnor, Pennsylvania, specializing in the development of innovative therapies for hypertension and related cardiovascular diseases. With a focused pipeline led by lorundrostat, the company aims to address significant unmet needs in the treatment of resistant hypertension. Its strategy centers on advancing proprietary, highly selective drug candidates through clinical development to capture market share in the cardiovascular therapeutics sector. Last August, Mineralys Therapeutics didn’t turn many heads when it reported that patients taking its lead candidate, lorundrostat, reduced their systolic blood pressure by 16.9 millimeters of mercury after six weeks of treatment. Later, when AstraZeneca (NYSE:AZN) reported less encouraging results from a similar candidate it’s developing, Mineralys stock shot higher. Continue reading
Liudmila Chernetska/iStock via Getty Images Thesis I present Alamos Gold ( AGI ) for investors bullish on gold. The gold mining company presents one of the best ways to amplify returns from a gold upside. Since I further argue the company trades at cheap valuations from a mine-by-mine analysis, the scope of multiple expansion along with gold price rises can amplify returns compared to just holding...
Liudmila Chernetska/iStock via Getty Images Thesis I present Alamos Gold ( AGI ) for investors bullish on gold. The gold mining company presents one of the best ways to amplify returns from a gold upside. Since I further argue the company trades at cheap valuations from a mine-by-mine analysis, the scope of multiple expansion along with gold price rises can amplify returns compared to just holding gold. This is only an investment for investors who at least have a neutral view on gold, and certainly not for gold bears. I further analyze and show that an upside ranging from 67% to 125% may materialize over the next two years, depending on whether gold trades near the current spot of $4,500/oz or increases further. I thus rate Alamos Gold a Strong Buy. Introduction Alamos Gold is a Toronto-based gold miner with a fairly simple business model. It operates three active mines, two of which are located in Canada and one in Mexico, from which it mines gold, processes it through on-site mills to produce doré bars, and gets it refined to market standards via third-party refineries, before selling the pure gold at spot prices. Hence, the business is heavily sensitive to gold prices, and if an investor is bullish on gold, this can be a leverage amplifier to gold returns. The Trend in Gold I am no gold macro expert, and there are far better analysts who can provide better commentary on the geopolitical and monetary forces driving gold. However, for people with a concrete bullish view on gold, Alamos is one of the best ways to get higher leverage on those returns. For people with no concrete view on gold, I recommend only considering this stock if you believe the current spot price of gold ($4,500) can be sustained. For bullion bears, this is not the stock for you. The Gold Math Alamos's revenue in any year is given simply by the ounces of gold sold, multiplied by the gold spot price. From that revenue, the company subtracts its AISC (All in Sustaining Costs), the industry standa...
Amax Photo/iStock via Getty Images Co-authored with Luuk Wierenga We all feel it every day when we go grocery shopping or fill up our tank at the gas station: inflation. Consumers are feeling the squeeze, and that's why consumer sentiment is at an all-time low. Smart people capitalize on opportunities when they arrive, which is why we are here today. When inflation rises, investors demand a higher...
Amax Photo/iStock via Getty Images Co-authored with Luuk Wierenga We all feel it every day when we go grocery shopping or fill up our tank at the gas station: inflation. Consumers are feeling the squeeze, and that's why consumer sentiment is at an all-time low. Smart people capitalize on opportunities when they arrive, which is why we are here today. When inflation rises, investors demand a higher return on their investments. Interest rates go higher, and the prices of fixed-income investments come down. This creates an interesting dynamic for investors to take advantage of. On the one hand, inflation drives higher interest rates, causing the price of fixed-income investments like bonds or preferred equity to come down. On the other hand, the American consumer is the backbone of the U.S. economy, and when the consumer breaks, the economy does as well. In a recession, the safety and consistency of fixed income are golden. This is why we are so interested in preferred shares right now. They offer a reliable and safe dividend. When times get rough, you look for safety. Comfort can be found in diversification and predictable cash flow. We have seen preferred securities move down in price recently because inflation is picking up, and long-term interest rates have moved higher. This creates an opportunity for us to increase our income by investing at a higher yield and buying investments that we are confident will produce stable cash flow through any economic conditions. Let's dive in! Pick #1: RLJ-A - Yield 7.8% RLJ Lodging Trust ( RLJ ) is a U.S. Hotel REIT that owns a portfolio of primarily premium-branded full-service hotels across major urban markets. Its strong exposure to high-quality brands like Hilton and Marriott supports resilient margins and cash flows. Source RLJ May 2026 Presentation RLJ Lodging Trust, $1.95 Series A, Cumulative Convertible Perpetual Preferred Shares ( RLJ.PR.A ) - Yield 7.7% RLJ-A Preferred Shares pay a quarterly dividend of $0.4875, or $1....
ozgurdonmaz/iStock via Getty Images Foreword While most of this collection of Dow Industrials is too pricey and reveals only skinny dividends, June (again) finds only Verizon ( VZ ) living up to the dogcatcher ideal of annual dividends from $1K invested exceeding single share price, and it is also 'safer' because it has more than enough free cash flow to support its dividend. In late February 2024...
ozgurdonmaz/iStock via Getty Images Foreword While most of this collection of Dow Industrials is too pricey and reveals only skinny dividends, June (again) finds only Verizon ( VZ ) living up to the dogcatcher ideal of annual dividends from $1K invested exceeding single share price, and it is also 'safer' because it has more than enough free cash flow to support its dividend. In late February 2024, Dow Jones replaced the low-priced, high-yield dividend payer Walgreens with Amazon ( AMZN ), a high-priced non-dividend payer. More recently, in November 2024, Intel ( INTC ) was replaced by Nvidia ( NVDA ) and Dow Inc. ( DOW ) was supplanted by Sherwin-Williams ( SHW ). With renewed downside market pressure, up to 70.3% of all ten of the top 'safer' May Dow dividend dogs could become elite, fair-priced buys with annual yield (from $1K invested) meeting or exceeding their single share prices. [See a summary of the top ten fair-priced Dow Dogs in A ctionable Conclusion 21 near the midpoint of this article.] Actionable Conclusions (1-10): Brokers Expect 17.15% To 45.09% Net Gains From Top-Ten Dow Dogs By June 2027 Four of ten top dividend-yielding Dow dogs (tinted gray in the chart below) were among the top ten price gainers for the coming year based on analyst 1-year target prices. So, this June 2027 yield-based forecast for Dow dogs, as graded by Wall St. wizard estimates, was 40% accurate. Dividend-returns estimated from $1,000.00 invested in each of the ten highest-yielding Dow stocks and one-year analyst median target prices, as reported by YCharts, produced the following 2026-27 data points. (Note: one-year target-prices estimated by lone analysts were not applied.) Ten likely profit-generating trades for June, 2027 were: Source: YCharts.com Salesforce ( CRM ) was projected to net $450.86, based on dividends, plus the median of target price estimates from 53 analysts, less broker fees. The Beta number showed this estimate subject to risk/volatility 14% over the market...